Patents by Inventor John Quin

John Quin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070179118
    Abstract: The present invention provides substituted 2-aminopyridines useful in treating cell proliferative disorders. The novel compounds of the present invention are potent inhibitors of cyclin-dependent kinases 4 (cdk4).
    Type: Application
    Filed: April 11, 2007
    Publication date: August 2, 2007
    Inventors: Mark Barvian, Richard Booth, John Quin, Joseph Repine, Derek Sheehan, Peter Toogood, Scott Vanderwel, Hairong Zhou
  • Publication number: 20050137214
    Abstract: The present invention provides substituted 2-aminopyridines useful in treating cell proliferative disorders. The novel compounds of the present invention are potent inhibitors of cyclin-dependent kinases 4 (cdk4).
    Type: Application
    Filed: January 28, 2005
    Publication date: June 23, 2005
    Inventors: Mark Barvian, Richard Booth, John Quin, Joseph Repine, Derek Sheehan, Peter Toogood, Scott Vanderwel, Hairong Zhou
  • Publication number: 20050026964
    Abstract: The present invention relates to 5-substituted-4-(substituted)phenylamino-2-pyridone derivatives, pharmaceutical compositions and methods of use thereof.
    Type: Application
    Filed: June 24, 2004
    Publication date: February 3, 2005
    Inventors: Shannon Black, Michael Kaufman, Daniel Ortwine, Mark Plummer, John Quin, Gordon Rewcastle, Aurash Shahripour, Julie Spicer, Christopher Whitehead
  • Publication number: 20020006936
    Abstract: The present invention provides compounds of Formula I 1
    Type: Application
    Filed: July 23, 2001
    Publication date: January 17, 2002
    Inventors: Jack Bikker, Ellen Myra Dobrusin, Annette Marian Doherty, Matthew Drowns, James Stanley Kaltenbronn, Juergen Kleinschroth, Dennis Joseph McNamara, John Quin, Joseph Thomas Repine, Marcin Stasiak